RSS-Feed abonnieren
DOI: 10.1590/0004-282X-ANP-2022-S122
A critical review and update on autoimmune encephalitis: understanding the alphabet soup
Revisão crítica e atualizações em encefalites autoimunes: entendendo a sopa de letrinhas
ABSTRACT
Autoimmune encephalitis (AE) comprises a group of diseases mediated by antibodies against neuronal cell surface or synaptic antigens, such as ion channels or neurotransmitter receptors. New clinical syndromes and their associated antibodies were and are still being characterized over the last two decades. The fact that their main clinical features are interdisciplinary, - encompassing neuropsychiatric symptoms, cognitive dysfunction, epileptic seizures, movement and sleep disorders - has led to a surge of interest in this field. Some of these diseases present with a well-defined syndrome, being recognizable on clinical grounds. Correct diagnosis is important since AE are potentially treatable diseases, despite their severity. On the other hand, an increasing number of neuronal antibodies being described casts doubt upon the way we should utilize antibody testing and interpret results. In this article we review, summarize and update the current knowledge on antibody mediated encephalitis.
RESUMO
As encefalites autoimunes compreendem um grupo de doenças mediadas por anticorpos contra antígenos de superfície neuronal ou sinapse, como canais iônicos ou receptores de neurotransmissores. Novas síndromes clínicas e os anticorpos a elas associados foram e ainda estão sendo caracterizados ao longo das últimas duas décadas. Dado que suas principais características clínicas são interdisciplinares, isto é, incluem -se sintomas neuropisquiátricos, disfunção cognitiva, crises epilépticas, distúrbio do movimento e do sono, há uma grande onda de interesse sobre esse campo de conhecimento. Algumas dessas doenças apresentam-se com uma síndrome bem definida, sendo possível reconhecê-las clinicamente. Diagnosticá-las corretamente é importante uma vez que se trata de doenças potencialmente tratáveis apesar da gravidade que lhes é característica. Por outro lado, o número crescente de anticorpos sendo descritos causam dúvida frequente sobre qual o melhor teste a solicitar e como interpretá-los. Nós aqui apresentamos uma revisão atualização resumida do conhecimento atual sobre as encefalites mediadas por anticorpos.
Keywords:
Encephalitis - Anti-N-Methyl-D-Aspartate Receptor Encephalitis - Limbic Encephalitis - Paraneoplastic Syndromes, Nervous System.Palavras-chave:
Encefalite - Encefalite Anti Receptor de N-Metil-D-Aspartato - Encefalite Límbica - Síndromes Paraneoplásicas do Sistema Nervoso.Authors’ contributions:
MMS: conceptualization, data curation, formal analysis, investigation, methodology, writing-original draft, writing-review & editing; GDS: conceptualization, formal analysis, methodology, validation, visualization; LHMC: conceptualization, formal analysis, methodology, validation, reviewing and editing; LTL: conceptualization, validation, visualization.
Publikationsverlauf
Eingereicht: 30. März 2022
Angenommen: 29. April 2022
Artikel online veröffentlicht:
06. Februar 2023
© 2022. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med 2018; 378 (09) 840-851 https://doi.org/10.1056/NEJMra1708712
- 2 Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T. et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016; 15 (04) P391-P404 https://doi.org/10.1016/S1474-4422(15)00401-9
- 3 Granerod J, Cousens S, Davies NW, Crowcroft NS, Thomas SL. New estimates of incidence of encephalitis in England. Emerg Infect Dis 2013; 19 (09) 1455-1462 https://doi.org/10.3201/eid1909.130064
- 4 Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D. et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010; 10 (12) P835-P844 https://doi.org/10.1016/S1473-3099(10)70222-X
- 5 Vora NM, Holman RC, Mehal JM, Steiner CA, Blanton J, Sejvar J. Burden of encephalitis-associated hospitalizations in the United States, 1998-2010. Neurology 2014; 82 (05) 443-451 https://doi.org/10.1212/WNL.2022s1222022s1220086
- 6 Dalmau J, Tüzün E, Wu H, Masjuan J, Rossi JE, Voloschin A. et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61 (01) 25-36 https://doi.org/10.1002/ana.21050
- 7 Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012; 54 (07) 899-904 https://doi.org/10.1093/cid/cir1038
- 8 van Sonderen A, Thijs RD, Coenders EC, Jiskoot LC, Sanchez E, de Bruijn MAAM. et al. Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology 2016; 87 (14) 1449-1456 https://doi.org/10.1212/WNL.2022s1222022s1223173
- 9 Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA. et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis: autoimmune encephalitis. Ann Neurol 2018; 83 (01) 166-177 https://doi.org/10.1002/ana.25131
- 10 Darnell RB, Posner JB. Paraneoplastic Syndromes. 1. Oxford (UK): Oxford University Press; 2011: 496-496
- 11 Brierley JB, Corsellis JAN, Hierons R, Nevin S. Subacute encephalitis of later adult life. Mainly affecting the limbic areas. Brain 1960; 83 (03) 357-368 https://doi.org/10.1093/brain/83.3.357
- 12 Graus F, Vogrig A, Muñiz-Castrillo S, Antoine J-CG, Desestret V, Dubey D. et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm 2021; 8 (04) e1014 https://doi.org/10.1212/NXI.2022s1222022s1221014
- 13 Dalmau J. NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: the 2016 Cotzias Lecture. Neurology 2016; 87 (23) 2471-2482 https://doi.org/10.1212/WNL.2022s1222022s1223414
- 14 Armangue T, Olivé-Cirera G, Martínez-Hernandez E, Sepulveda M, Ruiz-Garcia R, Muñoz-Batista M. et al. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study. Lancet Neurol 2020; 19 (03) P234-P246 https://doi.org/10.1016/S1474-4422(19)30488-0
- 15 Graus F, Dalmau J. Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors. Nat Rev Clin Oncol 2019; 16 (09) 535-548 https://doi.org/10.1038/s41571-019-0194-4
- 16 Armangue T, Spatola M, Vlagea A, Mattozzi S, Cárceles-Cordon M, Martinez-Heras E. et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol 2018; 17 (09) 760-772 https://doi.org/10.1016/S1474-4422(18)30244-8
- 17 Armangue T, Spatola M, Vlagea A, Mattozzi S, Cárceles-Cordon M, Martinez-Heras E. et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol 2018; 17 (09) 760-772 https://doi.org/10.1016/S1474-4422(18)30244-8
- 18 Spatola M, Petit-Pedrol M, Simabukuro MM, Armangue T, Castro FJ, Artigues MIB. et al. Investigations in GABAAreceptor antibody-associated encephalitis. Neurology 2017; 88 (11) 1012-1020 https://doi.org/10.1212/WNL.2022s1222022s1223713
- 19 Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M. et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry 2021; 92 (07) 757-768 https://doi.org/10.1136/jnnp-2020-325300
- 20 Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D. Extreme delta brush A unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 2012; 79 (11) 1094-1100 https://doi.org/10.1212/WNL.0b013e3182698cd8
- 21 van Sonderen A, Arends S, Tavy DLJ, Bastiaansen AEM, Bruijn MAAM, Schreurs MWJ. et al. Predictive value of electroencephalography in anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry 2018; 89 (10) 1101-1106 https://doi.org/10.1136/jnnp-2018-318376
- 22 Jeannin-Mayer S, André-Obadia N, Rosenberg S, Boutet C, Honnorat J, Antoine JC. et al. EEG analysis in anti-NMDA receptor encephalitis: description of typical patterns. Clin Neurophysiol 2019; 130 (02) 289-296 https://doi.org/10.1016/j.clinph.2018.10.017
- 23 Simabukuro MM, Petit-Pedrol M, Castro LH, Nitrini R, Lucato L, Zambon AA. et al. GABAA receptor and LGI1 antibody encephalitis in a patient with thymoma. Neurol Neuroimmunol Neuroinflamm 2015; 2 (02) e73 https://doi.org/10.1212/NXI.2022s1222022s1220073
- 24 Leypoldt F, Buchert R, Kleiter I, Marienhagen J, Gelderblom M, Magnus T. et al. Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry 2012; 83 (07) 681-686 https://doi.org/10.1136/jnnp-2011-301969
- 25 Probasco JC, Solnes L, Nalluri A, Cohen J, Jones KM, Zan E. et al. Decreased occipital lobe metabolism by FDG-PET/CT. Neurol Neuroimmunol Neuroinflamm 2018; 5 (01) e413 https://doi.org/10.1212/NXI.2022s1222022s1220413
- 26 Graus F, Dalmau J. Role of 18F-FDG-PET imaging in the diagnosis of autoimmune encephalitis - Authors’ reply. Lancet Neurol 2016; 15 (10) 1010 https://doi.org/10.1016/S1474-4422(16)30130-2
- 27 Nature Portfolio. Six factors affecting reproducibility in life science research and how to handle them [Internet]. 2022 Mar 15 Available from: https://www.nature.com/articles/d42473-019-00004-y
- 28 Guasp M, Giné-Servén E, Maudes E, Rosa-Justicia M, Martínez-Hernández E, Boix-Quintana E. et al. Clinical, neuroimmunologic, and CSF investigations in first episode psychosis. Neurology 2021; 97 (01) e61-e75 https://doi.org/10.1212/WNL.2022s1220000012191
- 29 Graus F, Dalmau J. Autoimmune encephalitis or autoimmune psychosis?. Eur Neuropsychopharmacol 2021; 50: 112-114 https://doi.org/10.1016/j.euroneuro.2021.05.004
- 30 Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T. et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12 (02) 157-165 https://doi.org/10.1016/S1474-4422(12)70310-1
- 31 Pollak TA, Lennox BR, Müller S, Benros ME, Prüss H, van Elst LT. et al. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiatry 2020; 7 (01) 93-108 https://doi.org/10.1016/S2215-0366(19)30290-1
- 32 Titulaer MJ, Day GS. Autoimmune encephalitis in first episode psychoses: all smoke and no fire?. Neurology 2021; 97 (01) 16-17 https://doi.org/10.1212/WNL.2022s1220000012195
- 33 Bastiaansen AEM, van Steenhoven RW, Bruijn MAAM, Crijnen YS, van Sonderen A, van Coevorden-Hameete MH. et al. Autoimmune encephalitis resembling dementia syndromes. Neurol Neuroimmunol Neuroinflamm 2021; 8 (05) e1039 https://doi.org/10.1212/NXI.2022s1222022s1221039
- 34 Schmerler DA, Roller S, Espay AJ. Teaching video neuroimages: faciobrachial dystonic seizures pathognomonic phenomenology. Neurology 2016; 86 (06) e60-e61 https://doi.org/10.1212/WNL.2022s1222022s1222359
- 35 Uy CE, Binks S, Irani SR. Autoimmune encephalitis: clinical spectrum and management. Pract Neurol 2021; 21 (05) 412-423 https://doi.org/10.1136/practneurol-2020-002567
- 36 Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y, Sangha N, Martinez-Lage M, Dalmau J. Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology 2011; 77 (06) 589-593 https://doi.org/10.1212/WNL.0b013e318228c136
- 37 Ariño H, Armangué T, Petit-Pedrol M, Sabater L, Martinez-Hernandez E, Hara M. et al. Anti-LGI1-associated cognitive impairment: presentation and long-term outcome. Neurology 2016; 87 (08) 759-765 https://doi.org/10.1212/WNL.2022s1222022s1223009
- 38 Scheibe F, Prüss H, Mengel AM, Kohler S, Nümann A, Köhnlein M. et al. Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis. Neurology 2017; 88 (04) 366-370 https://doi.org/10.1212/WNL.2022s1222022s1223536
- 39 Shin Y-W, Lee S-T, Kim T-J, Jun J-S, Chu K. Bortezomib treatment for severe refractory anti-NMDA receptor encephalitis. Ann Clin Transl Neurol 2018; 5 (05) 598-605 https://doi.org/10.1002/acn3.557
- 40 Behrendt V, Krogias C, Reinacher-Schick A, Gold R, Kleiter I. Bortezomib treatment for patients with Anti- N -Methyl- D -aspartate receptor encephalitis. JAMA Neurol 2016; 73 (10) 1251-1253 https://doi.org/10.1001/jamaneurol.2016.2588
- 41 Lee W-J, Lee S-T, Moon J, Sunwoo J-S, Byun J-I, Lim J-A. et al. Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study. Neurotherapeutics 2016; 13 (04) 824-832 https://doi.org/10.1007/s13311-016-0442-6
- 42 Bravo-Oro A, Abud-Mendoza C, Quezada-Corona A, Dalmau J, Campos-Guevara V. Encefalitis por anticuerpos contra el receptor de NMDA: experiencia con seis pacientes pediátricos. Potencial eficacia del metotrexato. Rev Neurol 2013; 57 (09) 405-410
- 43 Tatencloux S, Chretien P, Rogemond V, Honnorat J, Tardieu M, Deiva K. Intrathecal treatment of anti-N-Methyl-d-aspartate receptor encephalitis in children. Dev Med Child Neurol 2015; 57 (01) 95-99 https://doi.org/10.1111/dmcn.12545
- 44 Clinical Trials. The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis (ExTINGUISH) [Internet]. ClinicalTrials.gov. 2020 2022 Mar 29 Available from: https://clinicaltrials.gov/ct2/show/NCT04372615